Pfizer CEO made $5.6 mn stock sale on same day as Covid-19 vaccine update

CEO Albert Bourla authorized the sale of the shares on Aug. 19, provided the stock was at least at a certain price, as part of a predetermined plan, the company said

Pfizer Inc Chief Executive Officer Albert Bourla sold $5.56 million worth of company shares on Monday, the day the drugmaker said its Covid-19 vaccine was 90% effective based on interim trial results, a regulatory filing showed.
 

Bourla authorized the sale of the shares on Aug. 19, provided the stock was at least at a certain price, as part of a predetermined plan, the company said.
 

Bourla sold 132,508 shares at $41.94 per share, according to a Securities and Exchange Commission filing late Tuesday.

"The sale of these shares is part of Dr. Bourla's personal financial planning and a pre-established